376 related articles for article (PubMed ID: 21812902)
1. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S
BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902
[TBL] [Abstract][Full Text] [Related]
2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
4. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
5. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
7. Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre.
Boström PJ; Mirtti T; Kössi J; Laato M; Nurmi M
Scand J Urol Nephrol; 2009; 43(5):357-64. PubMed ID: 19921979
[TBL] [Abstract][Full Text] [Related]
8. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
10. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
Bruins HM; Wopat R; Mitra AP; Cai J; Miranda G; Skinner EC; Daneshmand S
BJU Int; 2013 Mar; 111(3 Pt B):E37-42. PubMed ID: 22974410
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
[TBL] [Abstract][Full Text] [Related]
15. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
Mitra AP; Skinner EC; Miranda G; Daneshmand S
BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
[TBL] [Abstract][Full Text] [Related]
16. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
[TBL] [Abstract][Full Text] [Related]
17. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
[TBL] [Abstract][Full Text] [Related]
18. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
19. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
